These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 93978

  • 1. Testicular cancer: role of biological tumor markers.
    Pearson JC, Spaulding JT, Friedman MA.
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N.
    Prog Clin Biol Res; 1985 Dec; 203():271-86. PubMed ID: 2421330
    [No Abstract] [Full Text] [Related]

  • 3. Radioimmunodetection of primary and secondary germ cell tumors.
    Van Cangh PJ, Ferrant A, Ninane J, Humblet Y, Deckers C.
    Prog Clin Biol Res; 1985 Dec; 203():127-38. PubMed ID: 2421326
    [No Abstract] [Full Text] [Related]

  • 4. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov 11; 2(8098):1042. PubMed ID: 82048
    [No Abstract] [Full Text] [Related]

  • 5. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N.
    J Urol; 1977 Dec 11; 118(6):994-9. PubMed ID: 72833
    [No Abstract] [Full Text] [Related]

  • 6. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N.
    Hum Pathol; 1979 Sep 11; 10(5):557-68. PubMed ID: 93569
    [Abstract] [Full Text] [Related]

  • 7. Tumor markers aid therapy of testicular cancer.
    JAMA; 1979 Jul 27; 242(4):320-1. PubMed ID: 87526
    [No Abstract] [Full Text] [Related]

  • 8. The value of biologic markers in diagnosis and treatment of testicular cancer.
    Javadpour N.
    Semin Oncol; 1979 Mar 27; 6(1):37-47. PubMed ID: 88072
    [No Abstract] [Full Text] [Related]

  • 9. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS, Klimenko IA, Iaremko VN, Zaparin VK.
    Klin Khir (1962); 1990 Mar 27; (5):47-8. PubMed ID: 1697352
    [No Abstract] [Full Text] [Related]

  • 10. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar KS, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J, National Comprehensive Cancer Network.
    J Natl Compr Canc Netw; 2006 Nov 27; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract] [Full Text] [Related]

  • 11. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE.
    N Engl J Med; 1976 Nov 25; 295(22):1237-40. PubMed ID: 62281
    [No Abstract] [Full Text] [Related]

  • 12. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ, Geller NL, Cirrincione C, Nisselbaum J, Vugrin D, Whitmore WF, Golbey RB.
    Am J Med; 1983 Jul 25; 75(1):29-35. PubMed ID: 6190398
    [Abstract] [Full Text] [Related]

  • 13. [Tumor markers in malignant tumors].
    Ogreid P.
    Tidsskr Nor Laegeforen; 1980 Apr 30; 100(12):678-9. PubMed ID: 6158119
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Apr 30; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 15. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK.
    Tumour Biol; 1987 Apr 30; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S, Arakawa S, Masuda M, Hamami G, Shimatani N, Itho N, Nakatsuka E, Fujii A, Ohono S, Ishigami J, Yoshimoto Y, Hattori M, Fujita T, Okada S.
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr 30; 71(4):352-62. PubMed ID: 6157042
    [No Abstract] [Full Text] [Related]

  • 17. A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT).
    Droz JP, Kramar A, Caillaud JM, Bellet D, Wibault P, Court BH.
    Prog Clin Biol Res; 1985 Apr 30; 203():269-70. PubMed ID: 2421329
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of stage I, II testicular tumor based on tumor markers].
    Kamidono S, Arakawa S, Hamami G, Umezu K, Fujii A, Ishigami J.
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug 30; 74(8):1383-93. PubMed ID: 6202917
    [No Abstract] [Full Text] [Related]

  • 19. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH.
    Natl Cancer Inst Monogr; 1978 Dec 30; (49):215-7. PubMed ID: 86163
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of biologic markers: Memorial Hospital experience.
    Barzell WE, Whitmore WF.
    Semin Oncol; 1979 Mar 30; 6(1):48-52. PubMed ID: 88073
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.